Research directory

Clinical trials

Find trials by company, ticker, title or NCT ID.

Filters
Reset
1,647 trials match your filters.
TrialSponsorPhaseStatusPrimary completion
Ropidoxuridine as a Radiosensitizer in Newly Diagnosed IDH-Wildtype Glioblastoma With Unmethylated MGMT PromoterNCT06359379Shuttle Pharmaceuticals, Inc.Phase 2Terminated2025-12-01Actual
Progressing TAAR-1, Dopamine, and Norepinephrine in Depression Using SolriamfetolNCT06360419AXSMPhase 3Completed2024-12-31Actual
A Study of Barzolvolimab in Patients With Prurigo NodularisNCT06366750Celldex TherapeuticsPhase 2Active not recruiting2026-03-17Actual
A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast CancerNCT06369285PBYIPhase 2Recruiting2027-12-30Estimated
A Study of Auxora in Patients With AKI and Injurious Lung "Crosstalk"NCT06374797CALCPhase 2Terminated2026-04-06Actual
Study Evaluating the Safety and Efficacy of RAP-219 in Adult Participants With Refractory Focal EpilepsyNCT06377930RAPPPhase 2Completed2025-09-26Actual
A Phase 2 Study of ZL-1102 in Patients With Chronic Plaque PsoriasisNCT06380907Zai Lab (Hong Kong), Ltd.Phase 2Terminated2025-12-16Actual
KYSA-7: A Study of Anti-CD19 CAR T-Cell Therapy, in Subjects With Refractory Primary and Secondary Progressive Multiple SclerosisNCT06384976Kyverna TherapeuticsPhase 2Active not recruiting2027-04Estimated
Dusquetide for the Treatment of Behcet's DiseaseNCT06386744SoligenixPhase 2Completed2025-05-23Actual
Namodenoson Treatment of Advanced Pancreatic CancerNCT06387342Can-Fite BioPharmaPhase 2Recruiting2026-07-15Estimated
A Phase 2/3 Study to Evaluate the Efficacy and Safety of Tinlarebant in Subjects With Stargardt DiseaseNCT06388083BLTEPhase 2, Phase 3Active not recruiting2028-02Estimated
A Phase 3 Study Of OCU400 Gene Therapy for the Treatment Of Retinitis PigmentosaNCT06388200OcugenPhase 3Active not recruiting2027-02-12Estimated
A Clinical Trial to Assess the Efficacy and Safety of Subjects With Dry Eye DiseaseNCT06389214ALDXPhase 3Completed2024-06-11Actual
A Pivotal Study of APG-2575 (Lisaftoclax) Combined With Azacitidine in the Treatment of Acute Myeloid LeukemiaNCT06389292Ascentage Pharma Group Inc.Phase 3Recruiting2028-05-25Estimated
EF-39 PANOVA-4: Study of Tumor Treating Fields Concomitant With Atezolizumab, Gemcitabine and Nab-Paclitaxel as First-LineTreatment for Metastatic Pancreatic Ductal AdenocarcinomaNCT06390059NVCRPhase 2Completed2025-11-18Actual
PD, PK, and Safety of ALTO-203 in Patients With MDDNCT06391593Alto NeurosciencePhase 2Completed2025-04-14Actual
Phase III Study of AK112 for NSCLC PatientsNCT06396065Summit TherapeuticsPhase 3Active not recruiting2025-04-12Actual
Study That Tests AD109 in Patients Taking GLP-1 DrugsNCT06400615ApnimedPhase 2Completed2024-12-26Actual
A Strain Change Study for SARS-CoV-2 rS VaccinesNCT06409663NovavaxPhase 3Completed2024-10-15Actual
Study to Evaluate the Efficacy and Safety of Subcutaneous Sonelokimab Compared With Placebo in Adult Participants With Moderate to Severe Hidradenitis SuppurativaNCT06411379MoonLake Immunotherapeutics AGPhase 3Completed2025-08-14Actual
A Study to Evaluate the Efficacy and Safety of Subcutaneous Sonelokimab Compared With Placebo in Adult Participants With Moderate to Severe Hidradenitis SuppurativaNCT06411899MoonLake Immunotherapeutics AGPhase 3Completed2025-09-02Actual
A Study to Evaluate the Effect of Aficamten in Pediatric Patients With Symptomatic Obstructive Hypertrophic Cardiomyopathy (oHCM).NCT06412666CytokineticsPhase 2, Phase 3Active not recruiting2030-01Estimated
Elucidating TAAR-1, Dopamine, and Norepinephrine in Binge Eating Disorder Using SolriamfetolNCT06413433AXSMPhase 3Recruiting2026-12Estimated
Long-term Extension of GTX-102 in Angelman SyndromeNCT06415344RAREPhase 3Active not recruiting2029-02Estimated
ICoN-1 Phase 3 Study of the Efficacy and Safety of Treatment With MNKD-101, Clofazimine Inhalation SuspensionNCT06418711Mannkind CorporationPhase 3Terminated2025-11-10Actual
A Phase 2 Study to Evaluate the Safety, PD, PK, and Clinical Activity of ADX-097 in Participants With IgAN, LN or C3GNCT06419205Akebia TherapeuticsPhase 2Recruiting2028-02Estimated
OLE Study of Carbetocin Nasal Spray for the Treatment of Hyperphagia in Prader-Willi SyndromeNCT06420297ACADPhase 3Terminated2025-12-19Actual
Clinical Trial to Evaluate the Efficacy of Gene Therapy for Pyruvate Kinase DeficiencyNCT06422351RCKTPhase 2Suspended2029-01Estimated
Study of Olverembatinib (HQP1351) in Patients With CML-CPNCT06423911Ascentage Pharma Group Inc.Phase 3Recruiting2027-06-30Estimated
A Clinical Trial to Assess the Safety and Efficacy of Subjects With Dry Eye DiseaseNCT06424444ALDXPhase 3Completed2024-11-03Actual

Primary completion marks the end of data collection for the main study measures, not a results publication date.